Vascular endothelial function and hypertension: Insights and directions

Current Hypertension Reports

Volumn 12, Issue 6, 2010, Pages 448-455

  Dharmashankar, Kodlipet ^a   Widlansky, Michael E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cardiovascular risk; Endothelium; Hypertension; Inflammation; Mineralocorticoid receptor; Mitochondria; NADPH oxidase; Nitric oxide; Oxidative stress; Sodium

Indexed keywords

ADIPOCYTOKINE; ALDOSTERONE ANTAGONIST; ALISKIREN; AMLODIPINE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; INTEGRIN LINKED KINASE; LISINOPRIL; LOSARTAN; NEBIVOLOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; NONHUMAN; REVIEW; SODIUM RESTRICTION; STROKE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; DIET, SODIUM-RESTRICTED; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HUMANS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MICE; MODELS, ANIMAL; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 78649905840     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0150-2     Document Type: Review

References (84)

1. BM Egan Y Zhao RN Axon 2010 US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2043 2050 1:CAS:528:DC%2BC3cXntVWrtLg%3D 10.1001/jama.2010.650 20501926
2. JA Whitworth 2003 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens 21 1983 1992 10.1097/00004872-200311000-00002 14597836 (Pubitemid 38296854)
3. ME Widlansky N Gokce JF Keaney Jr 2003 Vita JA: The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 1149 1160 1:CAS:528: DC%2BD3sXos1Wgur0%3D 10.1016/S0735-1097(03)00994-X 14522472 (Pubitemid 37188333)
4. Gokce N, Keaney JF Jr, Vita JA (1998) Endotheliopathies: Clinical manifestations of endothelial dysfunction. In: Loscalzo J, Shafer AI (eds) Thrombosis and Hemorrhage. Baltimore: Williams & Wilkins, pp 901-924.
5. JA Vita JF Keaney Jr 2002 Endothelial function: a barometer for cardiovascular risk? Circulation 106 640 642 10.1161/01.CIR.0000028581.07992.56 12163419 (Pubitemid 34851918)
6. MG Modena L Bonetti F Coppi, et al. 2002 Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J Am Coll Cardiol 40 505 510 10.1016/S0735-1097(02)01976-9 12142118 (Pubitemid 34833167)
7. •• Kitta Y, Obata JE, Nakamura T, et al.: Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009, 53:323-330. The authors measured endothelial function by brachial artery reactivity immediately following the diagnosis of cardiovascular disease in 251 patients and remeasured endothelial function 6 months after initiation of intensive therapy. Those with persistently impaired brachial artery reactivity had a significantly higher 3-year event rate (26%) than those with improved reactivity on therapy (10%). Persistent impairment of endothelial dysfunction was an independent predictor of cardiovascular risk.
8. CJ McMackin JA Vita 2005 Update on nitric oxide-dependent vasodilation in human subjects Methods Enzymol 396 541 553 1:CAS:528:DC%2BD28Xot1yht7w%3D 10.1016/S0076-6879(05)96046-1 16291261 (Pubitemid 41603575)
9. NM Hamburg EJ Benjamin 2009 Assessment of endothelial function using digital pulse amplitude tonometry Trends Cardiovasc Med 19 6 11 1:CAS:528:DC%2BD1MXmtlyjt7g%3D 10.1016/j.tcm.2009.03.001 19467447
10. RF Furchgott JV Zawadzki 1980 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373 376 1:CAS:528:DyaL3MXhtFCktbY%3D 10.1038/288373a0 6253831 (Pubitemid 11169009)
11. LJ Ignarro JC Edwards DY Gruetter, et al. 1980 Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds FEBS Lett 110 275 278 1:CAS:528:DyaL3cXhslKgtLc%3D 10.1016/0014-5793(80)80091-3 6102928
12. PL Ludmer AP Selwyn TL Shook, et al. 1986 Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N Engl J Med 315 1046 1051 1:STN:280:DyaL2s%2FhsVKitw%3D%3D 10.1056/NEJM198610233151702 3093861
13. DA Cox JA Vita CB Treasure, et al. 1989 Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans Circulation 80 458 465 1:STN:280:DyaL1MzlsFegsw%3D%3D 2527643
14. MC Corretti TJ Anderson EJ Benjamin, et al. 2002 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 257 265 10.1016/S0735-1097(01)01746-6 11788217 (Pubitemid 34084631)
15. EJ Benjamin MG Larson MJ Keyes, et al. 2004 Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study Circulation 109 613 619 10.1161/01.CIR.0000112565.60887.1E 14769683 (Pubitemid 38198868)
16. DG Harrison MC Gongora 2009 Oxidative stress and hypertension Med Clin North Am 93 621 635 1:CAS:528:DC%2BD1MXotFSqu70%3D 10.1016/j.mcna.2009.02.015 19427495
17. TJ Kizhakekuttu ME Widlansky 2010 Natural antioxidants and hypertension: promise and challenges Cardiovasc Ther 28 e20 e32 1:CAS:528:DC%2BC3cXhtFOiurnI 10.1111/j.1755-5922.2010.00137.x 20370791
18. JD Widder D Fraccarollo P Galuppo, et al. 2009 Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of thioredoxin 2 Hypertension 54 338 344 1:CAS:528:DC%2BD1MXosFWitLs%3D 10.1161/HYPERTENSIONAHA.108.127928 19506101
19. C Vecchione D Carnevale PA Di, et al. 2009 Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway Hypertension 54 1028 1034 1:CAS:528:DC%2BD1MXht1ymsr3O 10.1161/HYPERTENSIONAHA.109.136572 19770407
20. AK Doughan DG Harrison SI Dikalov 2008 Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction Circ Res 102 488 496 1:CAS:528:DC%2BD1cXitl2jsrg%3D 10.1161/CIRCRESAHA.107.162800 18096818 (Pubitemid 351651106)
21. SE Shoelson J Lee AB Goldfine 2006 Inflammation and insulin resistance J Clin Invest 116 1793 1801 1:CAS:528:DC%2BD28XmvV2ltLo%3D 10.1172/JCI29069 16823477
22. CM Apovian S Bigornia M Mott, et al. 2008 Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects Arterioscler Thromb Vasc Biol 28 1654 1659 1:CAS:528: DC%2BD1cXpvFKhtLg%3D 10.1161/ATVBAHA.108.170316 18566296
23. ZH Zeng ZH Zhang BH Luo, et al. 2009 The functional changes of the perivascular adipose tissue in spontaneously hypertensive rats and the effects of atorvastatin therapy Clin Exp Hypertens 31 355 363 1:CAS:528: DC%2BD1MXhtFansrrO 10.1080/10641960902977916 19811363
24. C Marchesi T Ebrahimian O Angulo, et al. 2009 Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome Hypertension 54 1384 1392 1:CAS:528:DC%2BD1MXhtl2qur3E 10.1161/HYPERTENSIONAHA. 109.138305 19822799
25. E Magen A Feldman Z Cohen, et al. 2010 Potential link between C3a, C3b and endothelial progenitor cells in resistant hypertension Am J Med Sci 339 415 419 10.1097/MAJ.0b013e3181c6a968 20453728
26. SP Didion DA Kinzenbaw LI Schrader, et al. 2009 Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction Hypertension 54 619 624 1:CAS:528:DC%2BD1MXpsleksbk%3D 10.1161/HYPERTENSIONAHA.109.137158 19620507
27. JM Hill G Zalos JP Halcox, et al. 2003 Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
28. S Wassmann N Werner T Czech G Nickenig 2006 Improvement of endothelial function by systemic transfusion of vascular progenitor cells Circ Res 99 e74 e83 1:CAS:528:DC%2BD28XhtVKjtL%2FJ 10.1161/01.RES.0000246095.90247.d4 16990568 (Pubitemid 44556373)
29. G Giannotti C Doerries PS Mocharla, et al. 2010 Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction Hypertension 55 1389 1397 1:CAS:528:DC%2BC3cXmt1altbc%3D 10.1161/HYPERTENSIONAHA.109.141614 20458006
30. FG Hage S Oparil D Xing, et al. 2010 C-reactive protein-mediated vascular injury requires complement Arterioscler Thromb Vasc Biol 30 1189 1195 1:CAS:528:DC%2BC3cXmt1altrY%3D 10.1161/ATVBAHA.110.205377 20339115
31. JA Vita CB Treasure EG Nabel, et al. 1990 Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease Circulation 81 491 497 1:STN:280:DyaK3c7isV2msQ%3D%3D 2105174
32. CB Treasure SV Manoukian JL Klein, et al. 1992 Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients Circ Res 71 776 781 1:STN:280:DyaK38zos1KgsA%3D%3D 1516154
33. JA Panza AA Quyyumi JE Brush SE Epstein 1990 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 22 27 1:STN:280:DyaK3c3oslagug%3D%3D 10.1056/NEJM199007053230105 2355955
34. JA Panza PR Casino CM Kilcoyne AA Quyyumi 1993 Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1468 1474 1:STN:280:DyaK3s3lvVyrsA%3D%3D 8491001
35. JA Panza CE Garcia CM Kilcoyne, et al. 1995 Impaired endothelium- dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway Circulation 91 1732 1738 1:STN:280:DyaK2M7ovVehug%3D%3D 7882481
36. M Sander B Chavoshan RG Victor 1999 A large blood pressure-raising effect of nitric oxide synthase inhibition in humans Hypertension 33 937 942 1:STN:280:DyaK1M3itFOjug%3D%3D 10205227
37. R Rossi E Chiurlia A Nuzzo, et al. 2004 Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women J Am Coll Cardiol 44 1636 1640 10.1016/j.jacc.2004.07.027 15489096 (Pubitemid 39369796)
38. JW Jurva SA Phillips AQ Syed, et al. 2006 The effect of exertional hypertension evoked by weight lifting on vascular endothelial function J Am Coll Cardiol 48 3 588 589 10.1016/j.jacc.2006.05.004 16875990 (Pubitemid 44093950)
39. M Juonala JS Viikari T Ronnemaa, et al. 2006 Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the Cardiovascular Risk in Young Finns Study Hypertension 48 424 430 1:CAS:528:DC%2BD28XnvFOjsrw%3D 10.1161/01.HYP.0000237666.78217.47 16880344 (Pubitemid 44253736)
40. •• Shimbo D, Muntner P, Mann D, et al.: Endothelial dysfunction and the risk of hypertension: the Multi-Ethnic Study of Atherosclerosis. Hypertension 2010, 55:1210-1216. The investigators measured endothelial function by brachial artery reactivity in 3500 ethnically diverse, nonhypertensive individuals in the Multi-ethnic Study of Atherosclerosis (MESA). Brachial reactivity was not found to be an independent predictor of the future development of hypertension after adjustment for other risk factors. This is the largest and most diverse study to address the question of directionality of the relationship of hypertension and endothelial dysfunction, and the data support the concept of endothelial dysfunction as an effect of hypertension rather than a cause of it.
41. AA Quyyumi RS Patel 2010 Endothelial dysfunction and hypertension: cause or effect? Hypertension 55 1092 1094 1:CAS:528:DC%2BC3cXkslOjt7k%3D 10.1161/HYPERTENSIONAHA.109.148957 20308609
42. •• Bibbins-Domingo K, Chertow GM, Coxson PG, et al.: Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599. The authors employed the Coronary Heart Disease Policy Model to determine the potential achievable reductions in cardiovascular risk from reducing dietary salt by up to 3 grams per day. The authors report that such a reduction would lead to significant reductions in stroke, myocardial infarction, and cardiovascular death.
43. He FJ, MacGregor GA: Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004, (3):CD004937.
44. L Kopkan DS Majid 2005 Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency Hypertension 46 1026 1031 1:CAS:528:DC%2BD2MXhtVektr7J 10.1161/01.HYP.0000174989.39003.58 16103275
45. L Kopkan DS Majid 2006 Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats Hypertension 47 568 572 1:CAS:528:DC%2BD28XhsFKlu7Y%3D 10.1161/01.HYP.0000200027.34925.93 16401762 (Pubitemid 43843877)
46. DS Majid L Kopkan 2007 Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension Clin Exp Pharmacol Physiol 34 9 946 952 1:CAS:528:DC%2BD2sXpslOjs7Y%3D 10.1111/j.1440-1681.2007.04642.x 17645645 (Pubitemid 47083962)
47. KL Jablonski PE Gates GL Pierce DR Seals 2009 Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure Ther Adv Cardiovasc Dis 3 347 356 10.1177/1753944709345790 19723834
48. • McCall DO, McGartland CP, McKinley MC, et al.: Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 2009, 119:2153-2160. Individuals with hypertension were randomized to either 1, 3, or 6 servings per day of fresh fruits and vegetables after a 1-month run-in period with less than 1 serving per day. Endothelial function was assessed by forearm blood flow using venous plethysmography at the beginning and end of the 12-week intervention period. The authors found a 6.2% increase in forearm blood flow for each single-portion increase in fresh fruits and vegetables, demonstrating that increasing fruit and vegetable consumption can improve a surrogate marker of cardiovascular risk.
49. E Anter SR Thomas E Schulz, et al. 2004 Activation of eNOS by the p38 MAP kinase in response to black tea polyphenols J Biol Chem 45 46637 46643 10.1074/jbc.M405547200 (Pubitemid 39518309)
50. ME Widlansky SJ Duffy NM Hamburg, et al. 2004 Effects of black tea consumption on plasma catechins, markers of oxidative stress and inflammation in patients with coronary artery disease Free Radic Biol Med 38 499 506 10.1016/j.freeradbiomed.2004.11.013
51. GB Mancini GC Henry C Macaya, et al. 1996 Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 94 258 265 1:CAS:528:DyaK28XltF2rsro%3D 8759064
52. A Prasad S Husain AA Quyyumi 1999 Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin J Am Coll Cardiol 33 796 804 1:CAS:528:DyaK1MXltVKhu7c%3D 10.1016/S0735-1097(98)00611-1 10080484
53. Y Higashi S Sasaki K Nakagawa, et al. 2000 A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study J Am Coll Cardiol 35 284 291 1:CAS:528:DC%2BD3cXhs1elsL4%3D 10.1016/S0735-1097(99)00561-6 10676671 (Pubitemid 30125515)
54. A Prasad T Tupas-Habib WH Schenke, et al. 2000 Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis Circulation 101 2349 2354 1:CAS:528:DC%2BD3cXktVGgt70%3D 10821809
55. N Tzemos PO Lim TM MacDonald 2001 Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study Circulation 104 511 514 1:CAS:528:DC%2BD3MXmvVSlt70%3D 10.1161/hc3001.094207 11479245
56. L Ghiadoni Y Huang A Magagna, et al. 2001 Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension J Hypertens 19 3 Pt 2 547 551 1:CAS:528: DC%2BD3MXis1Knsb8%3D 10.1097/00004872-200103001-00005 11327628 (Pubitemid 32280946)
57. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2981 2997 10.1001/jama.288.23.2981 (Pubitemid 35471160)
58. AV Chobanian GL Bakris HR Black, et al. 2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2560 2572 1:CAS:528: DC%2BD3sXjvFCqtrk%3D 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
59. B Dahlof RB Devereux SE Kjeldsen, et al. 2002 Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension study (LIFE): a randomised trial against atenolol Lancet 359 995 1003 1:CAS:528:DC%2BD38XisV2htrw%3D 10.1016/S0140-6736(02)08089-3 11937178 (Pubitemid 34286536)
60. LM Wing CM Reid P Ryan, et al. 2003 A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly N Engl J Med 348 583 592 1:CAS:528:DC%2BD3sXhtVyqt74%3D 10.1056/NEJMoa021716 12584366 (Pubitemid 36204952)
61. K Jamerson MA Weber GL Bakris, et al. 2008 Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2417 2428 1:CAS:528:DC%2BD1cXhsVCrurjJ 10.1056/NEJMoa0806182 19052124
62. L Ghiadoni A Magagna D Versari, et al. 2003 Different effect of antihypertensive drugs on conduit artery endothelial function Hypertension 41 1281 1286 1:CAS:528:DC%2BD3sXktVyntb4%3D 10.1161/01.HYP.0000070956.57418.22 12719441 (Pubitemid 36706078)
63. MS Zhou EA Jaimes L Raij 2004 Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats Am J Hypertens 17 167 171 1:CAS:528:DC%2BD2cXmvF2nsQ%3D%3D 10.1016/j.amjhyper. 2003.09.007 14751660 (Pubitemid 38125135)
64. T Imanishi H Tsujioka H Ikejima, et al. 2008 Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes Hypertension 52 563 572 1:CAS:528:DC%2BD1cXpvFKgs7o%3D 10.1161/HYPERTENSIONAHA.108.111120 18645051
65. E Yamamoto K Kataoka YF Dong, et al. 2009 Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice Hypertension 54 633 638 1:CAS:528:DC%2BD1MXpsleksbo%3D 10.1161/HYPERTENSIONAHA.109.133884 19597038
66. DZ Cherney V Lai JW Scholey, et al. 2010 Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study Diabetes Care 33 361 365 1:CAS:528:DC%2BC3cXitlaltrk%3D 10.2337/dc09-1303 19889802
67. B Pitt F Zannad WJ Remme, et al. 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 709 717 1:CAS:528:DyaK1MXmtVyrurk%3D 10.1056/NEJM199909023411001 10471456 (Pubitemid 29407370)
68. EL Schiffrin 2006 Effects of aldosterone on the vasculature Hypertension 47 312 318 1:CAS:528:DC%2BD28Xht1Cmsbg%3D 10.1161/01.HYP.0000201443.63240.a7 16432039 (Pubitemid 43740260)
69. D Sanz-Rosa MP Oubiña E Cediel, et al. 2005 Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences Antioxid Redox Signal 7 1294 1301 1:CAS:528:DC%2BD2MXos1erurg%3D 10.1089/ars.2005.7.1294 16115035 (Pubitemid 41232527)
70. JA Leopold A Cap AW Scribner, et al. 2001 Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability FASEB J 15 1771 1773 1:CAS:528:DC%2BD3MXmsFaqu7c%3D 11481225
71. JA Leopold YY Zhang AW Scribner, et al. 2003 Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide Arterioscler Thromb Vasc Biol 23 411 417 1:CAS:528:DC%2BD3sXhslWhsL4%3D 10.1161/01.ATV.0000056744.26901.BA 12615686 (Pubitemid 36337216)
72. JA Leopold A Dam BA Maron, et al. 2007 Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity Nat Med 13 189 197 1:CAS:528:DC%2BD2sXhsVykur0%3D 10.1038/nm1545 17273168
73. A Virdis MF Neves F Amiri, et al. 2002 Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 504 510 1:CAS:528:DC%2BD38Xntlams7Y%3D 10.1161/01.HYP.0000034738.79310.06 12364354
74. RS Vasan JC Evans MG Larson, et al. 2004 Serum aldosterone and the incidence of hypertension in nonhypertensive persons N Engl J Med 351 33 41 1:CAS:528:DC%2BD2cXltlOjsLY%3D 10.1056/NEJMoa033263 15229305 (Pubitemid 38857245)
75. JH Pratt 2008 A not-so-modest proposal that a "modest" increase in aldosterone causes hypertension and more Hypertension 51 39 40 1:CAS:528:DC%2BD1cXit12gtLY%3D 10.1161/HYPERTENSIONAHA.107.100024 18039981 (Pubitemid 350307099)
76. CA Farquharson AD Struthers 2002 Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy Clin Sci (Lond) 103 425 431 1:CAS:528:DC%2BD38XotVWltb8%3D
77. BM Schmidt S Oehmer C Delles, et al. 2003 Rapid nongenomic effects of aldosterone on human forearm vasculature Hypertension 42 156 160 1:CAS:528:DC%2BD3sXls1ajtLY%3D 10.1161/01.HYP.0000083298.23119.16 12860833 (Pubitemid 36944589)
78. MK Nishizaka MA Zaman SA Green, et al. 2004 Impaired endothelium- dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism Circulation 109 2857 2861 1:CAS:528:DC%2BD2cXksF2lur0%3D 10.1161/01.CIR.0000129307.26791.8E 15173035 (Pubitemid 38780298)
79. SJ Duffy ES Biegelsen RT Eberhardt, et al. 2005 Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation Hypertension 46 707 713 1:CAS:528:DC%2BD2MXhtV2htr%2FN 10.1161/01.HYP.0000184231.84465.62 16172426 (Pubitemid 43186742)
80. DF Kahn SJ Duffy D Tomasian, et al. 2002 Effects of black race on forearm resistance vessel function Hypertension 40 195 201 1:CAS:528: DC%2BD38XmtF2ktb0%3D 10.1161/01.HYP.0000024571.69634.ED 12154113 (Pubitemid 34840098)
81. S Park JB Kim CY Shim, et al. 2007 The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients J Hypertens 25 1279 1283 1:CAS:528:DC%2BD2sXmtlWns7Y%3D 10.1097/HJH. 0b013e3280f31b6e 17563542 (Pubitemid 46918808)
82. Nguyen Dinh CA, Griol-Charhbili V, Loufrani L, et al.: The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 2010, 24:2454-2463.
83. S Sakurabayashi-Kitade Y Aoka H Nagashima, et al. 2009 Aldosterone blockade by spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice Atherosclerosis 206 54 60 1:CAS:528:DC%2BD1MXhtVKlsLvF 10.1016/j.atherosclerosis.2009.01.039 19327775
84. K Tsuchiya T Yoshimoto Y Hirata 2009 Endothelial dysfunction is related to aldosterone excess and raised blood pressure Endocr J 56 553 559 1:CAS:528:DC%2BD1MXhsVert73N 10.1507/endocrj.K09E-014 19352049